Value Microcaps Motherboard

[micham2012]

cliffvb, others re VPHM:

You may have seen the following post on Yahoo VPHM message board from poster who follows the stock closely:

"Keep in mind, VPHM's guidance assumed no growth in prescriptions in 2005. It included only the price increases. Prescription growth is increasing at an accelerating pace. I think after factoring in the growth in sales due to increased prescription growth less the incremental cost of goods sold, the net incremental revenues that management did not factor in will at least equal the non operating net expenses that managemnet could not quantify due to the unknowns regarding conversion of the Senior Notes. As a result, if you do the simple math, you arrive at fully diluted EPS of $.95 a share. The foregoing assumes prescription growth will continue to increase through the remainder of the year and cover, but not exceed the net non operating expenses. If it exceeds non operating expenses and management's guidance on total operating expenses is still valid (adjusted for increased cost of goods sold), fully diluted EPS may be as much as $1.15 for 2005."

Thus, it appears that price increase at end of March is in the most recent company projections.

Steve